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Background-—The impact of hyperoxia, that is, supraphysiological arterial partial pressure of O2, on myocardial oxygen balance
and function in stable multivessel coronary artery disease (CAD) is poorly understood. In this observational study, we assessed
myocardial effects of inhalational hyperoxia in patients with CAD using a comprehensive cardiovascular magnetic resonance exam.
Methods and Results-—Twenty-ﬁve patients with stable CAD underwent a contrast-free cardiovascular magnetic resonance exam
in the interval between their index coronary angiography and subsequent revascularization. The cardiovascular magnetic resonance
exam involved T1 and T2 mapping for tissue characterization (ﬁbrosis, edema) as well as function imaging, from which strain
analysis was derived, and oxygenation-sensitive cardiovascular magnetic resonance imaging. The latter modalities were both
acquired at room air and after breathing pure O2 by face mask at 10 L/min for 5 minutes. In 14 of the 25 CAD patients (56%),
hyperoxia induced poststenotic myocardial deoxygenation with a subsequent oxygenation discordance across the myocardium.
Extent of deoxygenation was correlated to degree of stenosis (r=0.434, P=0.033). Hyperoxia-associated poststenotic
deoxygenation was accompanied by ipsiregional reduction of diastolic strain rate (1.390.57 versus 1.180.65; P=0.045) and
systolic radial velocity (37.4017.22 versus 32.8813.58; P=0.038). Increased T2, as well as lower cardiac index, and deﬁned
abnormal strain parameters on room air were predictive for hyperoxia-induced abnormalities (P<0.05). Furthermore, in patients
with prolonged native T1 (>1220 ms), hyperoxia reduced ejection fraction and peak strain.
Conclusions-—Patients with CAD and pre-existent myocardial injury who respond to hyperoxic challenge with strain abnormalities
appear susceptible for hyperoxia-induced regional deoxygenation and deterioration of myocardial function.
Clinical Trial Registration-—URL: http://www.clinicaltrials.gov. Unique identiﬁer: NCT02233634. ( J Am Heart Assoc. 2020;9:
e014739. DOI: 10.1161/JAHA.119.014739.)
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U ntil recently, a supranormal inspired oxygen fraction wasperceived to improve safety margins in acute medical
care, and its unrestricted use was ubiquitous. In 2010,
Moradkhan et al stated that hyperoxia was not perceived by
medical staff to be detrimental, because of conﬂicting evidence
and lack of prospective, randomized controlled studies.1
However, recent trials and meta-analyses suggest not only
potential advantages,2 but also negative effects of supraphys-
iological oxygen concentrations,3 particularly in patients with
acutemyocardial ischemia.4 Therefore, the European Society of
Cardiology has revised previous guidelines for oxygen therapy
in patients with acute coronary syndrome and recommends
supplemental oxygen in non–ST-segment–elevationmyocardial
infarction5 and ST-segment–elevation myocardial infarction6
only for patients with a peripheral oxygen saturation (SpO2) of
<90% or in respiratory distress. Adverse sequelae of hyperoxia
may be caused by increased activity of reactive oxygen species,
which directly impair tissue function and trigger subsequent cell
death.7 Other problems may arise owing to direct vasocon-
strictive effects of hyperoxia.8 Although hyperoxiamay increase
oxygen supply to tissues by the small increment of O2 dissolved
in plasma, it has not been conclusively clariﬁed whether, or
when, this outweighs the decrement of O2 delivery caused by
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hyperoxic coronary vasoconstriction. Previous studies have
consistently demonstrated a hyperoxia-induced reduction in
cardiac output.9 In an animal study with an acutely induced
signiﬁcant coronary artery stenosis and exposure to normox-
emia followed by hyperoxia, functional and oxygenation-
sensitive (OS) cardiac magnetic resonance (CMR) imaging has
elucidated some of these mechanisms.10 Hyperoxia decreased
coronary ﬂow in this model and failed to compensate for
coronary vasoconstriction. Hyperoxia impaired both oxygena-
tion and regional wall motion in the myocardial distal to the
stenosis. In addition, hyperoxia impaired left ventricular ejec-
tion fraction (LVEF) in the animal group with coronary stenosis
to a greater degree than in control animals without coronary
stenosis.10 So far, data assessing such effects in patients with
chronic nonacute coronary artery disease (CAD) have been
lacking. Beyond acute cardiac care, there are various clinical
scenarios, particularly in anesthesia and intensive care, where
CAD patients may be exposed to supraphysiological oxygen
tensions, suggesting the importance of further investigations.
This observational clinical study aims to describe the
effects of hyperoxia on global and regional myocardial
oxygenation and ventricular function in patients with stable
multivessel CAD.
Methods
The data that support the ﬁndings of this study are available
from the corresponding author upon reasonable request.
Participants
This was a single-center project performed at Bern University
Hospital, Inselspital, Switzerland (CADOS; Clinical Trials
Identiﬁer: NCT02233634). The study was approved by the
local ethics board, the Cantonal Ethics Committee of Bern
(Swissethics-ID: PB_2016-02124), and complies with the
Declaration of Helsinki. All subjects had given their written
informed consent before enrolment into this study.
The project was designed to investigate the effects of
blood gas changes on myocardial tissue oxygenation in
patients with stable CAD. Part of this work has already been
published in a publication describing the potential diagnostic
utility of a patient-controlled CO2 challenge to detect CAD.
11
Patients were recruited to participate if there was at least
1 vascular territory subtended by an untreated stenosis of
>50% diameter (percent diameter stenosis [%DS] by quanti-
tative coronary angiography), to be detected in a diagnostic
index angiography with intention to perform either a staged
percutaneous coronary intervention or coronary artery bypass
graft surgery. Further inclusion criteria were that CMR
scanning could be performed before completion of revascu-
larization, and also that there was a nonobstructed coronary
vascular territory subtending at least 2 adjacent segments
(according to the American Heart Association 17-segment
model), in order to serve as intraindividual control tissue. All
participants were required to be aged >18 years, capable of
providing written informed consent, not be pregnant, or with
the presence any standard magnetic resonance imaging
contraindications. Patients with acute myocardial infarction
within <4 weeks preceding the magnetic resonance imaging
exam, with pre-existent coronary bypass grafts, or with severe
pulmonary disease were excluded.
Healthy control participants were recruited by public
advertisement, were required to be aged <35 years, non-
smokers for the past 6 months, free of any medication that
would affect the cardiac or circulatory system and with a
medical history free of cardiac or pulmonary disorders, or
other disorders known to affect the microvasculature. All
participants were asked to refrain from consuming caffeine
within 12 hours before the exam.
Quantitative Coronary Angiography
Quantitative coronary angiography was performed from the
angiography images (assessed following routine nitroglycerin
administration) obtained in the index angiography. The %DS of
all coronary arteries ≥1.5 mm was determined by the Bern
Clinical Perspective
What Is New?
• Hyperoxia induced an oxygenation discordance across the
myocardium in 56% of patients with coronary artery disease
as detected by cardiovascular magnetic resonance, and
regional deoxygenation in poststenotic myocardium was
correlated to degree of stenosis.
• Only patients with a myocardial oxygenation discordance
during hyperoxia showed a decrease in left ventricular
ejection fraction and cardiac index.
• At room air, several imaging parameters, such as baseline
myocardial deformation and edema, were identiﬁed as
markers that could potentially predict deteriorating myocar-
dial oxygenation and function attributed to hyperoxia.
What Are the Clinical Implications?
• Utility of supplemental oxygen in patients with stable
coronary artery disease is controversial, with studies
reporting both positive and negative results.
• Cardiovascularmagnetic resonancehasthepotential to identify
predictors of worsening myocardial oxygenation and function
during hyperoxia in patients with coronary artery disease.
• These results lay the framework for larger studies to assess
the prognostic role of these responses and investigate the
future role of imaging parameters for tailoring oxygen
therapy to the individual patient.
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University CoreLab with analysts concealed for the magnetic
resonance imaging analysis (QangioXA version 7.3; Medis
Medical Imaging Systems, Leiden, The Netherlands). To allow
a comparison between results from angiography and CMR,
this reader coded each myocardial segment as either (1)
remote, perfused by a nondiseased coronary branch; (2)
affected by a relevant stenosis (%DS >50%); or (3) reperfused
by percutaneous coronary intervention with a stent during
index angiography.
CMR Protocol
CMR imaging was performed using a clinical 3 Tesla magnetic
resonance imaging system (MAGNETOM Skyra; Siemens
Healthcare, Erlangen, Germany).
The CMR included native pixel-wise parametric T1 and T2
mapping in a basal and mid-ventricular short-axis slice, while
participants breathed room air (RA), with normoxemia conﬁrmed
by pulse oximetry (SpO2 ≥94%). The 5(3)3-modiﬁed Look–Locker
sequence was used for T1 mapping (repetition time/echo time
281/1.12 ms, ﬂip angle 35 degrees, voxel size 1.491.49
8.0 mm, and bandwidth 1085 Hz/Px). T2 maps were generated
after acquiring 3 single-shot gradient echo images (repetition
time/echo time 207/1.32 ms, ﬂip angle=12 degrees, voxel size
1.991.998.0 mm, and bandwidth 1184 Hz/Px) at different T2
preparation times of 0, 30, and 55 ms.
Standard cine acquisition for ventricular function analysis of
7 to 10 short-axis slices and OS-CMR12 in a basal and a mid-
ventricular short-axis slice were acquired, ﬁrst, during normox-
emia and, second, during hyperoxia after breathing 100%
oxygen with a clinical oxygen mask with reservoir bag at 10 L/
min for 5 minutes. For function imaging, a standard gated
balanced steady-state free precession cine sequence was used
(repetition time/echo time 3.3/1.43 ms, temporal resolution
44.8 ms, ﬂip angle 65 degrees, voxel size 1.691.696.0 mm,
matrix 1929120, and bandwidth 962 Hz/Px). OS-CMR was
imaged using a triggered balanced steady-state free precession
sequence (repetition time/echo time 3.4/1.70 ms, ﬂip angle
35 degrees, voxel size 2.092.0910.0 mm, matrix 1929120,
and bandwidth 1302 Hz/Px).12 Noninvasive blood pressure,
heart rate, and standard pulse oximetry were monitored and
recorded throughout the exam. Occurrence of any adverse
effects was documented.
CMR Image Blinding and Analysis
CMR images were recoded and the reader was blinded for the
group (patient versus control) or sequence allocation (breathing
RA or 100% oxygen), the angiography, and pulse oximetry data.
Changes in myocardial oxygenation are expressed as changes in
percent signal intensity betweenOS-CMR images acquiredunder
normoxemic and hyperoxic conditions, with manual tracing of
epi- and endocardial contours using cvi42 (Circle Cardiovascular
Imaging, Calgary, AB, Canada) by an experienced reader.
Standard cardiac function parameters were calculated,
including LVEF, cardiac index (CI), end-diastolic and end-
systolic volumes, and myocardial mass, each indexed to body
surface area. Using feature-tracking software, strain param-
eters were calculated for the left ventricle from cine images
(excluding slices containing outﬂow tract and mitral valve
planes). Peak strain (PS), time to PS, systolic strain rate, and
early diastolic strain rate (e-dSR) were obtained in both radial
and circumferential orientation. Measures of peak displace-
ment, time to peak displacement, and systolic and early
diastolic velocity were reported for radial orientation. Mea-
surements from strain analysis and OS-CMR are reported as
global values and also for myocardium subtended to the
stenosed vessel (poststenotic territory, based on angiography
results). Regional myocardial oxygenation response to hyper-
oxia was further categorized as concordant or discordant.
Discordance was assumed when oxygenation response in
poststenotic myocardium decreased more than in myocar-
dium perfused by a patent coronary vessel (remote territory).
Statistical Analysis
Continuous data are reported as mean and SD, and categor-
ical data as frequency and percentage. Radial and circumfer-
ential feature-tracking results are denoted with letters R or C.
Measurements obtained at hyperoxia were compared with
normoxemic measurements using paired t testing for contin-
uous variables or chi-square and Fisher’s exact tests for
categorical variables. For testing the effects of T1 prolonga-
tion on global and regional hyperoxic response, patients were
grouped according to a global T1 <1220 or ≥1220 ms (using
our local cutoff for normal T1). Linear association with
quantitative coronary angiography results was explored with
Spearman’s correlation test. Univariate linear regression was
used to identify potential markers at normoxemia associated
with hyperoxia-induced oxygenation discordance. Multivariate
analysis was not performed owing to the small sample size.
Nonparametric equivalents were used, if appropriate. Tests
were performed with GraphPad Prism (version 8.0; GraphPad
Software Inc, La Jolla, CA) and SPSS software (version 26;
SPSS IBM, Armonk, NY). Results were considered statistically
signiﬁcant at a 2-tailed P<0.05.
Results
Participant Characteristics
Participant characteristics and indications for the index
angiography are shown in Table 1. All patients had at least
1 vessel with a relevant coronary artery stenosis, deﬁned as a
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%DS >50% (mean, 6315%; chronic total occlusion, n=3).
Twenty-two patients (88%) had a percutaneous coronary
intervention performed on 1 vessel during the initial visit with
a good result; 3 patients had diagnostic angiography and were
subsequently scheduled for percutaneous coronary interven-
tion (n=1) or coronary artery bypass graft surgery (n=2).
Hyperoxia did not induce changes of heart rate or systolic
blood pressure in patients (Table 2), but healthy controls
experienced an increase in diastolic blood pressure from
546 to 607 mm Hg (P=0.002). The change from breathing
RA to hyperoxia by O2 insufﬂation increased SpO2 from
961% (CAD patients) and 971% (healthy controls),
respectively, to above 991% in both groups (P<0.001).
Hyperoxic Response of Myocardial Oxygenation
The global change in myocardial signal intensity was compa-
rable between healthy participants (1.43.5%) and patients
(0.64.0%; P=0.572). In poststenotic territories of patients,
this response was 0.93.7% with a maximum decrease of
7.4%. Degree of deoxygenation correlated signiﬁcantly with
an increasing %DS of the corresponding coronary artery
(r=0.434; P=0.033). In poststenotic myocardium, no rela-
tionship between hyperoxic oxygenation response and
changes in ventricular function was observed.
Hyperoxic Response of Ventricular Function and
Strain Parameters
In healthy participants, hyperoxia did not signiﬁcantly affect
global ventricular function or CI (Table 2). In theCADpopulation,
CI decreased signiﬁcantly with hyperoxia, from 2.890.84 to
2.750.79 L/min/m2 (P=0.040).
In feature-tracking analysis, both healthy controls and CAD
patients showed global reduction of systolic parameters like
systolic strain rate and velocities when exposed to hyperoxia.
In the CAD group, however, there was greater variability and
baseline measurements on room air already indicated some
functional impairment. In both groups, hyperoxia signiﬁcantly
prolonged circumferential time to peak strain (controls, from
29125 to 31135 ms [P=0.010]; CAD, from 32858 to
34664 ms [P=0.017]). Only CAD patients demonstrated
signiﬁcant hyperoxia-induced deterioration of global e-dSR
(0.940.44/s at normoxemia versus 0.800.32/s at hyper-
oxia; P=0.048).
In myocardium distal to the stenosis in CAD patients,
hyperoxia resulted in slowing of diastolic relaxation in both
radial and circumferential orientation (radial e-dSR: 3.171.
46 versus 2.761.56; P=0.038; circumferential e-dSR:
1.390.57 versus 1.180.65; P=0.045). Speciﬁcally, the
poststenotic myocardium of patients exhibited deterioration
of radial systolic strain rate and velocity (radial systolic strain
rate: 2.561.39 versus 2.320.97; P=0.056; radial systolic
velocity: 37.4017.22 versus 32.8813.58; P=0.038),
whereas this was not observed in remote territories.
Figures 1 and 2 show exemplary patients with discordant
hyperoxia-induced oxygenation response and changes in
systolic and diastolic function parameters.
Discord of Hyperoxia-Induced Changes of
Myocardial Oxygenation and Function
Discordance of hyperoxia-induced myocardial oxygenation
responses and its relationship to myocardial function param-
eters were explored. In the CAD group, a regionally discordant
myocardial oxygenation response to hyperoxia was shown in
56%, that is, with attenuated response in poststenotic when
compared with that of remote territories. Presence of regional
oxygenation discordance was associated with hyperoxia-
induced reduction of LVEF (CAD with discordance:
4.05.3%, versus CAD with concordance: +0.74.0%;
P=0.026).
Association Between Parameters of Myocardial
Injury and Systolic Function
In comparison with healthy controls (119636 ms), CAD
patients showed prolonged T1 (124448 ms; P=0.008;
Table S1). Patient response to hyperoxia was dichotomized
into 2 categories based on a baseline T1 mapping value of
<1220 ms (normal reference range) or 1220 ms and longer
(prolonged, signifying myocardial injury). Patients with pro-
longed normoxemic baseline T1 showed signiﬁcantly reduced
Table 1. Baseline Characteristics
Controls (n=10)
Patients With
CAD (n=25)
Age, years 274 6411
Sex, female, n (%) 4 (40) 3 (12)
BMI, kg/m2 23.92.3 27.44.5
T1, ms 119636 124448
T2, ms 38.41.7 40.22.9
QCA (%DS) 6315
Days since index angiography 3710
Indication for index angiography
STEMI 5 (20)
NSTEMI 13 (52)
Stable angina 7 (28)
MeanSD or n (%) are displayed. BMI indicates body mass index; CAD, coronary artery
disease; NSTEMI, non–ST-segment–elevation myocardial infarction; QCA (%DS),
quantitative coronary angiography as percent diameter stenosis; STEMI, ST-segment–
elevation myocardial infarction.
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systolic function parameters LVEF and radial and circumfer-
ential PS during hyperoxia, which was in contrast to CAD
patients with a baseline T1 of <1220 ms (Figure 3).
Functional Deterioration in Patients With
Myocardial Oxygenation Discordance in
Hyperoxia
In 5 patients (25%), induction of hyperoxia reduced global
LVEF to below 50%. In every one of these cases, mapping of
myocardial oxygenation revealed regionally discordant
responses (P=0.034). Also, in each of the 7 patients (28%)
whose CI decreased to <2.5 L/min/m2 at hyperoxia, regional
myocardial oxygenation was discordant (P=0.008).
Indicators of Hyperoxia-Induced Myocardial
Oxygenation Discordance
Univariate analysis was performed to assess which parame-
ters at normoxemia could indicate regionally discordant
oxygenation of the myocardium at hyperoxia (Figure 4). Of
the clinical measurements, a low stroke volume index and
subsequent low CI were associated with discordance, but not
ejection fraction. All markers from feature-tracking except for
Table 2. Hemodynamics, Ventricular Function, and FT-CMR at Normoxia and Hyperoxia
Controls Patients With CAD
Room Air O2 P Value Room Air O2 P Value
Hemodynamics
Heart rate, bpm 6610 6413 0.472 6212 6110 0.332
Systolic BP, mm Hg 10710 11115 0.230 13016 13217 0.312
Diastolic BP, mm Hg 546 607 0.002* 758 769 0.594
SpO2, % 96.61.2 99.40.7 <0.001* 96.31.3 99.20.8 <0.001*
LV function
Ejection fraction, % 68.47.1 69.34.9 0.161 60.011.6 58.311.8 0.127
End-diastolic volume index, mL/m2 8516 9018 0.952 7515 7614 0.452
End-systolic volume index, mL/m2 265 276 0.360 3012 3112 0.186
Stroke volume index, mL/m2 5815 6214 0.609 4410 4411 0.857
Cardiac index, L/min/m2 4.061.10 3.871.23 0.051 2.890.84 2.750.79 0.040*
Mass index, g/m2 6315 6811
FT-CMR
Circumferential
Peak strain, % 22.02.0 21.01.7 0.149 19.74.1 19.44.1 0.219
Time to peak strain, ms 29125 31135 0.010* 32851 34664 0.017*
Systolic strain rate, /s 1.250.38 1.170.24 0.608 0.990.29 0.960.25 0.152
Diastolic strain rate, /s 1.780.31 1.630.38 0.316 0.940.44 0.800.32 0.048*
Radial
Peak strain, % 42.66.3 39.36.0 0.090 37.111.3 36.411.2 0.411
Time to peak strain, ms 29426 31830 0.010* 32649 33956 0.193
Systolic strain rate, /s 2.470.61 2.110.58 0.005* 1.950.81 1.800.62 0.072
Diastolic strain rate, /s 3.220.64 2.830.52 0.055 1.890.92 1.710.66 0.158
Displacement, mm 7.020.93 6.580.84 0.032* 6.551.47 6.511.40 0.589
Time to displacement, ms 29426 31248 0.176 33354 34471 <0.001*
Systolic velocity, mm/s 38.378.73 35.669.23 0.011* 32.299.48 31.317.90 0.304
Diastolic velocity, mm/s 55.4814.23 49.428.87 0.125 33.4017.40 30.6816.10 0.089
Global measurements are displayed as meanSD. BP indicates blood pressure; bpm, beats per minute; CAD, coronary artery disease; FT-CMR indicates feature tracking cardiovascular
magnetic resonance; LV, left ventricular; SpO2, peripheral oxygen saturation.
*P<0.05 indicates a signiﬁcant change from normoxemia (room air) to hyperoxia.
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time to peak were associated with discordance, with the
highest correlation coming from peak displacement and
diastolic strain rate and velocities in the radial orientation.
Presence of a more-recent myocardial injury indicated by an
elevated T2 showed a relationship to a hyperoxia-induced
oxygenation mismatch, whereas a nonsigniﬁcant trend was
observed with T1 (P=0.056).
Discussion
The main ﬁnding of this observational study is that more than
half (56%) of the CAD patients in our cohort experienced
regional myocardial deoxygenation in response to inhalational
hyperoxia. This was not observed in any of the healthy control
subjects. Myocardial deoxygenation in poststenotic segments
during hyperoxia was correlated with diameter of the
respective stenosis. Poststenotic segments also exhibited a
signiﬁcant reduction of e-dSR. The latter is an early marker of
myocardial ischemia, whereas systolic dysfunction is
observed later in the ischemic cascade, after diastolic
function is already impaired.13 Also, in poststenotic segments,
a reduction of systolic velocity and a trend to decreased
systolic strain rate were apparent.
A subset of CAD patients responded more severely to
hyperoxia, experiencing a global decrease of LVEF to <50%
(25% of patients) and a decrease of CI to <2.5 L/min/m2
(28% of patients). These were exclusively patients with a
hyperoxia-induced oxygenation discordance (Figure 1).
Figure 1. Exemplary coronary artery disease patient with hyperoxia-induced decrease of global systolic and diastolic function. This patient had a
maximal left anterior descending coronary artery (LAD) diameter stenosis of 61% (A) at CMR (cardiovascular magnetic resonance). The left
circumﬂex coronary artery with a left-dominant pattern was reperfused (stented) after presenting with a non–ST-segment–elevation myocardial
infarction 44 days before the staged percutaneous coronary intervention and CMR. Left ventricular ejection fraction decreased below 50% and
cardiac index below 2.5 L/min/m2 during hyperoxia (B). The T1 mapping image (C, top) shows myocardial injury in the subendocardial layer of the
anteroseptal segment (orange). This matches a hyperoxia-induced oxygenation deﬁcit (blue; C, bottom) observed in the LAD territory. This further
corresponded to a regional decrease in early diastolic circumferential peak strain rate (D). Diastolic SR indicates diastolic strain rate; OS (%), %
change in oxygenation-sensitive signal intensity.
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Patients with globally prolonged native T1 appeared prone to
hyperoxia-induced deterioration of PS and LVEF. In patients
with normal T1, these parameters were within 1 SD of PS and
LVEF of healthy participants during both normoxemia and
hyperoxia (Figure 3). In contrast, patients with prolonged native
T1 had PS and LVEF at RA, which were already outside the 1-SD
range of healthy controls, and this deteriorated further during
hyperoxia. Prolonged native T1 is a marker of abnormal tissue
composition.14 Mild prolongation is an indicator of ﬁbrosis,
whereas myocardial edema induces a more-marked T1 prolon-
gation. Discrimination of these 2 entities requires contrast-
enhanced T1 studies or addition of, and cross-referencing with,
water content-speciﬁc T2 maps.15 Presence of elevated T1
alone could be a marker of potential aggravating effects of
hyperoxia in CAD patients. The ﬁndings of myocardial edema in
poststenotic territories of some patients may indicate a more-
vulnerable myocardium prone to repetitive ischemia given that
our data show an association between the global increase of
myocardial T2 and development of a hyperoxia-induced regional
oxygenation discordance.
In our series, patients with globally impaired diastolic and
systolic function at normoxemia, as demonstrated by
reduction of strain parameters, stroke volume index, and
myocardial edema (globally prolonged T2), were prone to
hyperoxia-induced regional oxygenation discordance. Only
patients with regional oxygenation discordance showed
severe impairment of LVEF and CI, whereas low LVEF at RA
did not predict hyperoxia-induced deterioration of myocardial
function. This suggests a potential utility of CMR-based strain
analysis and tissue characterization for identifying CAD
patients who will not tolerate hyperoxia well. In the future,
larger studies are needed to demonstrate whether CMR
markers of tissue injury, inducible regional oxygenation
discordance, and hemodynamic depression are indeed pre-
dictors of clinical outcomes in patients receiving supplemen-
tal hyperoxic respiratory gas mixtures.
Figure 2. Exemplary patient with systolic dysfunction. Findings in an 80-year-old male patient with serial left anterior descending artery
stenoses (C, maximal degree: 63% diameter stenosis). This patient had a previous percutaneous coronary intervention of serial right coronary
artery stenoses following presentation with typical stable angina and inconclusive ergometry. In this patient, left ventricular ejection fraction
dropped from 64% to 57% and cardiac index from 2.77 to 2.37 L/min/m2 after breathing oxygen, respectively. The T1 mapping image (A, top)
shows myocardial injury in the septum and inferior wall, which is colocalized with both the oxygenation deﬁcit (A, bottom) and circumferential
strain (PSC) abnormalities induced with hyperoxia. At rest, the septum exhibits subnormal peak circumferential strain at end-systole (B), which is
exacerbated further at hyperoxia (yellow region). The graph shows that peak circumferential strain in poststenotic segments is attenuated
across the entire cardiac cycle at hyperoxia (green) in comparison with normoxemia at room air (black). OS (%) indicates % change in
oxygenation-sensitive signal intensity.
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Clinical Implications
There is increasing recognition that routine generation of
supraphysiological oxygen tensions may be harmful. Retro-
spective and prospective studies suggest detrimental effects
of excessive oxygen administration in patients with acute
myocardial ischemia or in patients after cardiac arrest.4,16,17
However, these results are matched by studies that report no
harm.18–21 Publications intermittently emerge that hold a
case for or against hyperoxia versus normoxemia. Neverthe-
less, the European Society of Cardiology has reinforced its
recommendations in favor of a more-restrictive oxygen
therapy in the guidelines of 2015 and 2017 for management
of acute coronary syndrome and ST-segment–elevation
myocardial infarction, respectively, and now advises treat-
ment with supplemental oxygen only below an SpO2 value
<90% or in respiratory distress.5,6
Apart from acute cardiac care, supraphysiological oxygen
tensions are administered to stable CAD patients in many other
clinical situations (ie, in anesthesia, critical care, and emergency
medicine). Robust data on the value of supraphysiological
oxygen supplementation to this patient group without ongoing
ischemia are even scarcer and the issue remains even more
controversial. A systematic review and meta-analysis has
investigatedmorbidity andmortality in critically ill adults treated
with liberal (SpO2 >94%) versus conservative oxygen therapy,
and found evidence of high quality that liberal oxygen therapy
may increase mortality without improving other outcomes.3
The number of patients with CAD or other cardiovascular
comorbidity undergoing major cardiac and noncardiac surgery
is increasing, amounting in Europe to 5.7 million procedures
each year.22 Up to 42% of complications occurring with
noncardiac surgery are attributed to cardiovascular causes,
adding up to 167 000 cardiac complications annually in Europe,
of which 19 000 are life-threatening.22,23 A signiﬁcant contrib-
utor may be myocardial injury after noncardiac surgery (MINS),
which has recently gained more attention. MINS is reported to
occur in up to 41% of patients undergoing noncardiac surgery
with diagnosed or risk for CAD. This results in an increase in
cardiac troponin levels, and depending on the cut-off values,
this is an independent predictor of 30-day mortality of up to
17%.23,24 The cause for MINS is likely to be multifactorial;
however, some research groups have ventured to try and
identify triggers for MINS. It has long been thought that volatile
anesthetics exert cardioprotective effects; however, the study
by Lurati Buse et al showed no difference between volatile and
total intravenous anesthesia in regard to incidence of MINS.25
More recently, it has also been shown that there is no difference
in outcome between volatile anesthesia versus total intra-
venous anesthesia in patients undergoing cardiac surgery.26
Another group currently investigates the effect of a protocolized
blood pressure regime (NCT02533128) and the effect of
incidence of MINS. Our results suggest that hyperoxia in CAD
patientsmay account for some of theMINS cases, which should
be elaborated on in future studies. Interestingly, iatrogenic
perioperative hyperoxia may be a potential contributor to
adverse outcome. The Danish PROXI (Perioperative oxygen
fraction—effect on surgical site infection and pulmonary
complications after abdominal surgery) trial, comparing 80%
versus 30% oxygen at laparotomies, found an increase in long-
term mortality after exposure to perioperative hyperoxia.27 In
addition, the post hoc analysis described an increased
incidence of new acute coronary syndrome (2.5% in the 80%
oxygen group versus 1.3% in the 30% oxygen group; hazard
ratio, 2.15 [95% CI, 0.96–4.84]).28 Long-term risk of myocardial
infarction was also signiﬁcantly increased in the 80% oxygen
group (hazard ratio, 2.86 [95% CI, 1.10–7.44]; P=0.03),
suggesting that perioperative hyperoxia may adversely affect
cardiovascular health even over prolonged periods of time.
Figure 3. Association between parameters of myocardial injury
and hyperoxic ventricular function. Patients with indicators of
myocardial injury (T1 ≥1220 ms, purple) demonstrate reduced
ejection fraction (EF) and peak strain in both circumferential (PSC)
and radial (PSR) orientation, all of which signiﬁcantly differ from
those in patients with T1 <1220 ms (orange, P=0.017, 0.025, and
0.047, respectively). Shaded green areas represent reference
ranges, with the darker shade indicating mean1 SD of healthy
control measurements at normoxemia (room air) and the lighter
shade representing the 2 SD cutoff.
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The ﬁndings of this study support our working hypothesis
that in a subset of patients with stable multivessel CAD,
hyperoxia may trigger potentially adverse effects. Neverthe-
less, there appear to be patients who beneﬁt from hyperoxia,
whereas others do not. So far, there is no technique to
distinguish CAD patients who may beneﬁt from hyperoxia
from those to whom hyperoxia may be harmful. More insight
into the cardiovascular pathophysiology of hyperoxia by using
advanced imaging technology and an improved ability to
discriminate between patients who beneﬁt from or deteriorate
under hyperoxic conditions would facilitate targeted and
individualized oxygen therapies in the future.
Limitations
This study recruited patients with stable multivessel CAD, of
whom a majority had had a previous revascularization
procedure. This is a confounder given that reperfused
segments may be affected by edema, ﬁbrosis, and scar, as
well as pre-existing wall motion abnormalities. Nevertheless,
this setting is very representative for the majority of CAD
patients. We assessed the severity of coronary artery stenosis
by quantitative coronary angiography measurements rather
than fractional ﬂow reserve (ie, the invasive gold standard).
Also, microvascular disease was not quantiﬁed. In addition,
we did not assess scar or myocardial ﬁbrosis by using
contrast-enhanced T1 mapping and calculation of extracellular
volume maps. OS images are susceptible to artifacts within
regions of interest, which can degrade image quality and lead
to exclusion of segments.
When designing the study, we chose to recruit younger
participants in good general health given that they were most
likely to have minimal microvascular or other cardiovascular
dysfunction. An age-matched control group would have been
more appropriate, but would have introduced the confounding
effect of increased ﬁbrotic load attributable to remodeling
with age. Of note, oxygenation response of this control group
was similar to that of an older healthy cohort in our previous
publication.12,29 Further research should also study why
healthy controls showed some impairment of systolic function
parameters as well, even in the absence of cardiovascular
disease, and whether this is of any consequence considering
Figure 4. Indicators of regional myocardial oxygenation discordance. The plot shows the correlation
coefﬁcient (r) with 95% CI demonstrating the association between measurements obtained at normoxemia
and hyperoxia-induced myocardial oxygenation discordance (56% of patients). Green indicates P<0.05.
Increasingly positive values are considered abnormal for circumferential peak strain and systolic strain rate,
as well as for radial diastolic velocity and strain rate. FT-CMR indicates feature tracking cardiovascular
magnetic resonance; LV, left ventricular.
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that these measurements remained within normal ranges.
This direction could also be expanded to investigate the
magnitude of changes between patients and healthy controls,
whereas our work focused on the impact of hyperoxia within
the individual groups.
Conclusions
Patients with CAD and pre-existent myocardial injury who
respond to hyperoxic challenge with strain abnormalities
appear susceptible for hyperoxia-induced regional deoxygena-
tion and deterioration of myocardial function. Further research
in larger cohorts is warranted to conﬁrm these ﬁndings and
validate risk prediction for adverse outcomes from nonthera-
peutic hyperoxia. In the future, this may lead to a more-
individualized oxygen therapy in acute coronary patient care.
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SUPPLEMENTAL MATERIAL
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Table S1. Impact of Myocardial Injury on the Ventricular Response to 
Hyperoxia. 
Normal T1 
(<1220ms) 
Abnormal T1 
(≥1220ms) 
p-value
LV Function 
Ejection Fraction (%) 2.3±3.4 -3.3±5.2 0.017* 
End Diastolic Volume Index (ml/m2) 2±5 1±8 0.852 
End Systolic Volume Index (ml/m2) -1±2 2±5 0.092 
Stroke Volume Index (ml/m2) 3±6 -1±6 0.132 
Cardiac Index (L/min/m2) 0.00±0.41 -0.20±0.40 0.303 
FT-CMR 
Circumferential 
Peak Strain (PSC, %) -0.6±1.1 0.8±1.6 0.025* 
Time to Peak Strain (TTPC, ms) 6±30 23±37 0.298 
Systolic Strain Rate (sSRC, /s) -0.03±0.09 0.05±0.11 0.093 
Diastolic Strain Rate (e-dSRC, /s) -0.03±0.19 -0.18±0.57 0.505 
Radial 
Peak Strain (PSR, %) 2.0±3.9 -2.0±5.4 0.047* 
Time to Peak Strain (TTPR, ms) 1±22 19±59 0.454 
Systolic Strain Rate (sSRR, /s) -0.05±0.35 -0.18±0.39 0.485 
Diastolic Strain Rate (e-dSRR, /s) -0.00±0.20 0.24±0.75 0.407 
Displacement (DispR, mm) 0.3±0.6 -0.2±0.6 0.120 
Time to Displacement  (TTDR, ms) 11±34 12±38 0.956 
Systolic Velocity (sVelR, mm/s) 1.28±3.7 -1.53±3.72 0.123 
Diastolic Velocity (e-VelR, mm/s) 3.41±8.25 0.95±6.11 0.482 
The mean±SD delta responses of ventricular function and feature tracking (FT-CMR) 
measurements are displayed for CAD patients with normal (<1220 ms) or elevated 
(≥1220ms) T1. Patients with elevated T1 indicating myocardial injury experienced 
significant deterioration of ejection fraction and peak strain in response to hyperoxia.  
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